AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
VANCOUVER, BC – AbCellera (Nasdaq: ABCL) announced that it has expanded its existing collaboration with AbbVie Inc. (NYSE: ABBV) to include the discovery of T-cell engagers (TCE) in oncology. The… Read More




